FEBS Open Bio-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2020-03-16 烽火很忙

纯生信分析，没做基础实验验证，有可能收吗?

158 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2023-06-06 ms9000000883741867 来自广东省

偏重的研究方向：干细胞
经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心

70 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2024-02-22 ms3000000324888221 来自湖北省

请问Under变成Under Review是外审的意思吗？

35 0

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2022-11-25 diyizhaozhao 来自上海

审稿速度:2.0 | 投稿命中率:25.0
经验分享：Pending Decision,会持续多久？

82 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2023-03-29 ms9000000014139256 来自重庆

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：基因功能
经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展

68 0

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2023-03-08 1defbc5bm21(暂无匿称) 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肺癌;生物;肿瘤
经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。
2022-8-9 Submitted
2022-9-15 Major Revision
2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据）
2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕
2023-2-8 Accept
2023-2-13 格式修改和图文摘要
2023-2-16 返回修改稿
2023-2-24 针对部分原始WB数据再次核查和处理
2023-2-27 返回修改稿
2023-3-3 正式 Accept
2023-3-4 通知版权**和版面费缴费
2023-3-6 完成版权**和缴费
2023-3-7 提前在线发表

68 0

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2023-02-02 眰恦-GT 来自浙江省

审稿速度:6.0 | 投稿命中率:5.0
经验分享：很慢

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2022-06-24 ms1000000252533959

还是under review

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2020-11-10 伊术

6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci

149 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=586726, encodeId=e5fe586e268c, content=纯生信分析，没做基础实验验证，有可能收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/253ec4d94f720dd8d7ff9fd9eee11139.jpg, createdBy=75232378321, createdName=烽火很忙, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141051, encodeId=f8eb214105157, content=偏重的研究方向：干细胞 经验分享：6.2投稿显示submitted， 6.6查看已有ID号和EIC，ADM，显示Under Review，是已经送外审了吗？这么快吗？之前好像有看到评论说Under Review变成小写的under review才是送外审、、、、担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93515629021, createdName=ms9000000883741867, createdTime=Tue Jun 06 11:29:48 CST 2023, time=2023-06-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188773, encodeId=0e712188e73d9, content=请问Under变成Under Review是外审的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b08766740, createdName=ms3000000324888221, createdTime=Thu Feb 22 21:33:15 CST 2024, time=2024-02-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2102599, encodeId=684d21025995e, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Pending Decision,会持续多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Fri Nov 25 14:23:03 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2122432, encodeId=9ba22122432c2, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因功能 经验分享：还挺快的，是转投的这个杂志，2.4号投稿，3.17号返回意见，小修。3.29号（今天）给编辑返回修改稿了，期待下一部进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=005f6502857, createdName=ms9000000014139256, createdTime=Wed Mar 29 10:58:06 CST 2023, time=2023-03-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118239, encodeId=2abe21182392e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肺癌;生物;肿瘤 经验分享：在medsci上获得很多网友分享投稿经验，很感谢，以下供参考。一篇小文章，选刊就选了相对稳的，没有折腾，但从投稿到在线弄了7个月，中间因为实验室**和新冠感染耽误了大概1个月，后又因为作者邮箱问题耽误了半个月。期刊不是毕业神刊，着急毕业的不适合；会核查WB和荧光图像原始数据，包括自动和人工两种方式，所以平时实验一定要保存好原始数据。 2022-8-9 Submitted 2022-9-15 Major Revision 2022-12-29 new Revision Submitted（包含WB和荧光图像原始数据） 2023-1-16 有个作者邮箱填写出现问题，中间这半个月一直没进展；作者邮箱问题处理完毕 2023-2-8 Accept 2023-2-13 格式修改和图文摘要 2023-2-16 返回修改稿 2023-2-24 针对部分原始WB数据再次核查和处理 2023-2-27 返回修改稿 2023-3-3 正式 Accept 2023-3-4 通知版权**和版面费缴费 2023-3-6 完成版权**和缴费 2023-3-7 提前在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=631e1736149, createdName=1defbc5bm21(暂无匿称), createdTime=Wed Mar 08 09:06:48 CST 2023, time=2023-03-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2112768, encodeId=f32a2112e68a1, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f2b5257506, createdName=眰恦-GT, createdTime=Thu Feb 02 17:39:23 CST 2023, time=2023-02-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1228414, encodeId=858b122841456, content=还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95615477411, createdName=ms1000000252533959, createdTime=Fri Jun 24 12:24:22 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898309, encodeId=932b898309a2, content=6.30投稿，7.20返回审稿人意见，大修后9.27返修回去，要求WB原始条带。10.27编辑来信被接受，并被要求完善些内容，还要去图文摘要。因为作者列表变动，需提供全部作者签名的声明，不过编辑蛮好说话的。11.10来信说被完全接受了,继续完善费用和出版问题。太高兴了，人生第一篇sci, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BCD5988F5BC7F7CCA1F304C4CFABE3AB/100, createdBy=c7842189530, createdName=伊术, createdTime=Tue Nov 10 18:31:13 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215242, encodeId=e92e1215242b4, content=请问版面费是多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d3b6467947, createdName=ms8000001202342739, createdTime=Thu Apr 28 09:36:30 CST 2022, time=2022-04-28, status=1, ipAttribution=)]

2022-04-28 ms8000001202342739

请问版面费是多少呢？

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务